Functional assessment using short tests in a patient with Pompe disease receiving enzyme replacement therapy: case report
Introduction: Pompe disease is characterized by the deficiency of the acid alfa glucosidase enzyme, which leads to a glycogen accumulation mainly in cardiac and skeletal muscles. Its onset may be early or late; the late form is more difficult to handle given the variety of presentations. Enzyme re...
Saved in:
| Main Authors: | Thomas Torres-Cuenca, Jorge Arturo Díaz-Ruíz, Fernando Ortiz-Corredor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidad Nacional de Colombia
2019-07-01
|
| Series: | Case Reports |
| Subjects: | |
| Online Access: | https://revistas.unal.edu.co/index.php/care/article/view/76711 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis
by: Mark Corbett, et al.
Published: (2025-08-01) -
Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
by: Barry J. Byrne, et al.
Published: (2024-10-01) -
Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
by: Barry J. Byrne, et al.
Published: (2025-01-01) -
Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?
by: Paulo José Lorenzoni, et al. -
Pompe Disease: Early Diagnosis and Early Treatment Make a Difference
by: Yin-Hsiu Chien, et al.
Published: (2013-08-01)